1. Urinary 2- to 16α-hydroxyestrone ratio did not change with cruciferous vegetable intake in premenopausal women.
- Author
-
Davis SJ, Arscott SA, Goltz S, Muir C, Binkley N, and Tanumihardjo SA
- Subjects
- Humans, Female, Adult, Middle Aged, Hydroxyestrones urine, Dietary Supplements, Brassicaceae chemistry, Brassica chemistry, Diet, Breast Neoplasms prevention & control, Breast Neoplasms urine, Biomarkers urine, Premenopause urine, Vegetables
- Abstract
The mass ratio of urinary 2-hydroxyestrone to 16-α-hydroxyestrone (2:16) is hypothesized as a biomarker of breast cancer risk in premenopausal women, with higher ratios being theoretically protective. Cruciferous vegetable intake has been associated with higher urinary 2:16 in some studies. We investigated whether a whole-food supplement made from dried Brussels sprouts and kale would increase urinary 2:16 in comparison with placebo or cruciferous vegetables in women. This randomized, parallel arm, placebo-controlled, partly blinded study included 78 healthy premenopausal women (38-50 y) with screening urinary 2:16 ≤3.0. Subjects received either six capsules containing 550 mg dried Brussels sprouts and kale per capsule, 40 g daily alternating broccoli or Brussels sprouts, or placebo for eight weeks. Urinary 2:16 and creatinine were measured at baseline, four, and eight weeks. Intent-to-treat repeated measures-ANOVA with multiple imputation ( n =100) for missing values identified no treatment effect ( P =0.9) or treatment-by-time interaction ( P =0.6); however, a significant time effect was noted ( P =0.02). Per-protocol analyses including complete cases found no treatment effect ( P =1) or treatment-by-time interaction ( P =0.6); however, the significant time effect remained ( P =0.03). Restricting analysis to subjects with >80% compliance maintained the time effect ( P =0.02). Using Pearson correlations, android-pattern and android:gynoid fat were predictive of change ( P ≤0.05). In conclusion, neither cruciferous supplements nor an added vegetable serving altered urinary 2:16 in premenopausal women with eight weeks treatment. This ratio did vary with time, which is important for designing future trials.
- Published
- 2024
- Full Text
- View/download PDF